Share This Page
Explore the Possibilities
and Advance with Us.
Apply
Refer a Friend
Back
Post Doctoral Associate
Job Number: 2014-23935
Category: Post Doc
Location: Worcester, MA
Shift: Day
Exempt/Non-Exempt: Exempt
Business Unit: SCHOOL
Department: School - RNA Therapeutics Institute - W405400
Job Type: Full-Time
Salary Grade: 86
Union Code: Non Union Position-W63-Residents/Post Docs
Num. Openings: 1
Post Date: Sept. 19, 2014

Overview:

 

Post-doctoral positions are available immediately in Dr. Xue's lab (http://www.umassmed.edu/xuelab/) to study the role of tumor suppressor genes in liver cancer using in vivo CRISPR. 

Responsibilities:

 

The goal is to determine whether CRISPR-mediated direct mutagenesis of tumor suppressor genes can identify novel liver cancer genes in mouse models.  The laboratory is interested in building new CRISPR tools to understand the network of cancer genes in liver and lung cancers, focusing on the p53, Pten and Ras pathways.  

Qualifications:

 

We seek motivated candidates with a PhD and background in cancer cell biology to join this new lab.  Experience in mouse cancer models is strongly desired.  The exceptional training environment within the RNA Therapeutics Institute at UMASS Medical School offers an interactive research environment covering RNA biology, RNA therapeutics, and model organisms. 

 

To apply, please send your CV, a brief description of your research experience, and contact information of at least three references, to Wen.Xue@umassmed.edu.

UMass Medical School is committed to being an equal opportunity and affirmative action employer and recognizes the power of a diverse community. We encourage applications from protected veterans, individuals with disabilities and those with varied experiences, perspectives and backgrounds to consider UMass Medical School as their employer of choice.

Apply
Check Out Our Advancing Careers 
HR Blog
UMass Chan is a Boston Globe 'Top Place to Work' Two Years in a Row!
Published Nov. 30, 2023

Diversity, Equity and Inclusion Practices at UMass Chan Recognized
Published Nov. 30, 2023

UMass Chan Medical School was among 23 companies that stood out as 2023 “DEI champions,” according to The Boston Globe.   

Named a U.S. News & World Report
“2023 BEST MEDICAL GRAD SCHOOL”
for Primary Care and Research